Back

Feeder cell - the key component in producing scalable and fit NK cells for therapeutic use

Saari, M.; Jahan, F.; Andersson, L.; Syreeni, A.; Vehmaan-Kreula, P.; Koski, J.; Jarvela, E.; Kerkela, E.; Paavilainen, H.; Schenkwein, D.; Yla-Herttuala, S.; Vettenranta, K.; Goos, H.; Korhonen, M.

2026-04-23 immunology
10.64898/2026.04.21.718880 bioRxiv
Show abstract

Natural killer (NK) cells are increasingly recognized as a versatile therapeutic platform, yet their translation is hindered by limited ex vivo proliferation. Feeder cells serve as robust stimulatory component supplying activating signals required to initiate large-scale NK cell expansion. Here, using bench-scale cultures, we evaluated how distinct engineered K562-based feeder cells influence NK cell proliferation, phenotype maintenance, potential for activation, and post-cryopreservation function. Across conditions, feeder-based systems consistently enabled superior, up to 500-fold higher NK cell yield compared to feeder-free system. Variants incorporating membrane-bound costimulatory and cytokine cues yielded the most favorable balance between expansion and functional preservation. Simple adjustments to cryopreservation, including high-density-freezing and centrifuge-free-thawing, further supported NK cell recovery. Together, these findings highlight feeder cells as essential upstream reagents for effective NK cell bioproduction and provide foundational biological insights to guide the rational design and validation of future scalable NK cell manufacturing platforms. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/718880v1_ufig1.gif" ALT="Figure 1"> View larger version (74K): org.highwire.dtl.DTLVardef@1e8e8baorg.highwire.dtl.DTLVardef@720d4org.highwire.dtl.DTLVardef@1fc7ce2org.highwire.dtl.DTLVardef@16b0fca_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 15 journals account for 50% of the predicted probability mass.

1
Advanced Science
249 papers in training set
Top 2%
8.7%
2
Lab on a Chip
88 papers in training set
Top 0.3%
5.0%
3
Advanced Functional Materials
41 papers in training set
Top 0.6%
4.4%
4
Nature Communications
4913 papers in training set
Top 37%
4.1%
5
Communications Biology
886 papers in training set
Top 1%
4.1%
6
Frontiers in Immunology
586 papers in training set
Top 2%
4.1%
7
Cytotherapy
14 papers in training set
Top 0.1%
3.4%
8
eLife
5422 papers in training set
Top 30%
2.8%
9
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 26%
2.4%
10
Journal of Controlled Release
39 papers in training set
Top 0.4%
2.2%
11
Stem Cell Reports
118 papers in training set
Top 0.3%
2.1%
12
Nature Biotechnology
147 papers in training set
Top 4%
1.8%
13
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.2%
1.8%
14
Science Advances
1098 papers in training set
Top 16%
1.7%
15
iScience
1063 papers in training set
Top 13%
1.7%
50% of probability mass above
16
Scientific Reports
3102 papers in training set
Top 57%
1.7%
17
Blood Advances
54 papers in training set
Top 0.8%
1.5%
18
Advanced Healthcare Materials
71 papers in training set
Top 1%
1.5%
19
Cell Reports Medicine
140 papers in training set
Top 5%
1.4%
20
Cell Systems
167 papers in training set
Top 9%
1.3%
21
ACS Synthetic Biology
256 papers in training set
Top 2%
1.3%
22
Nature Biomedical Engineering
42 papers in training set
Top 1%
1.1%
23
Clinical and Translational Science
21 papers in training set
Top 0.7%
1.0%
24
PLOS ONE
4510 papers in training set
Top 62%
1.0%
25
Journal of the American Chemical Society
199 papers in training set
Top 4%
0.9%
26
EMBO Molecular Medicine
85 papers in training set
Top 3%
0.9%
27
Cell Reports Methods
141 papers in training set
Top 4%
0.9%
28
Small
70 papers in training set
Top 1%
0.8%
29
Advanced Biology
29 papers in training set
Top 0.9%
0.8%
30
Computational and Structural Biotechnology Journal
216 papers in training set
Top 8%
0.8%